World Street Fundamentals
A Brighter Decade Ahead for Biotech – Industry Report Featuring Sareum Holdings Plc and Angel Biotechnology Holdings Plc
World Street Fundamentals / Key word(s): Forecast/Miscellaneous
Today, www.WorldStreetFundamentals.com released its industry report highlighting Sareum (LSE: SAR) (ISIN: GB00B02RFS12) and Angel Biotechnology Holdings Plc (LSE: ABH) (ISIN: GB00B0HZJ337). To read the full report, visit www.WorldStreetFundamentals.com.
Biotech is enabling creation of new drugs at a faster pace than the traditional pharmaceutical model and some believe that after a decade of mediocre performance it is approaching an inflection point. Companies are much more conducive to focusing on productivity and the sector is showing signs of being back to top growth by 2013 due to the opportunity emerging markets have created.
Contact: End of Corporate News 03.03.2011 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
114279 03.03.2011 |